Fundamentals of Pediatric Cancer: How Pediatric Pathology and Infrastructure of Clinical Trials Impact Contemporary Interventional Oncology in Children

Abstract

Pediatric cancer, though rare compared with adult malignancy, remains a significant cause of morbidity and mortality, with approximately 15,000 new diagnoses and over 1,500 deaths annually in the United States. Advances in multimodal therapy and cooperative group clinical trials have improved overall survival rates to over 80% in developed nations. Pediatric interventional oncology, a subset of pediatric interventional radiology (IR), has expanded beyond its role in biopsy and vascular access to include tumor-targeted and supportive care interventions. However, challenges in the field remain, including less pediatric-specific data and limited access to pediatric-trained interventional radiologists. Multidisciplinary collaboration is important for the integration of pediatric interventional oncology as a key component of pediatric cancer treatment.

Keywords

pediatric interventional oncology - pediatric interventional radiology - pediatric cancer - tumor biopsy

Publication History

Article published online:
16 July 2025

• References

• 1 Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin 2024; 74 (01) 12-49
• 2 Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023; 73 (01) 17-48
• 3 Rodriguez-Galindo C, Friedrich P, Alcasabas P. et al. Toward the cure of all children with cancer through collaborative efforts: pediatric oncology as a global challenge. J Clin Oncol 2015; 33 (27) 3065-3073
• 4 Elsayed M, Solomon SB. Interventional oncology: 2043 and beyond. Radiology 2023; 308 (01) e230139
• 5 Shpanskaya K, Lungren MP, Tulin-Silver S. Pediatric interventional oncology: endovascular, percutaneous, and palliative procedures. Semin Roentgenol 2019; 54 (04) 359-366
• 6 Bittles MA, Hoffer FA. Interventional radiology and the care of the pediatric oncology patient. Surg Oncol 2007; 16 (03) 229-233
• 7 Kattner P, Strobel H, Khoshnevis N. et al. Compare and contrast: pediatric cancer versus adult malignancies. Cancer Metastasis Rev 2019; 38 (04) 673-682
• 8 Shaikh R, Munoz FG. Endovascular approaches in pediatric interventional oncology. CVIR Endovasc 2021; 4 (01) 2
• 9 Allen-Rhoades W, Whittle SB, Rainusso N. Pediatric solid tumors in children and adolescents: an overview. Pediatr Rev 2018; 39 (09) 444-453
• 10 Pfister SM, Reyes-Múgica M, Chan JKC. et al. A summary of the inaugural WHO classification of pediatric tumors: transitioning from the optical into the molecular era. Cancer Discov 2022; 12 (02) 331-355
• 11 Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 2014; 64 (02) 83-103
• 12 Brodeur GM, Nichols KE, Plon SE, Schiffman JD, Malkin D. Pediatric cancer predisposition and surveillance: an overview, and a tribute to Alfred G. Knudson Jr. Clin Cancer Res 2017; 23 (11) e1-e5
• 13 Janeway KA, Place AE, Kieran MW, Harris MH. Future of clinical genomics in pediatric oncology. J Clin Oncol 2013; 31 (15) 1893-1903
• 14 Sun T, Zhang H, Gao W, Yang Q. The appropriate number of preoperative core needle biopsy specimens for analysis in breast cancer. Medicine (Baltimore) 2021; 100 (14) e25400
• 15 Metz T, Heider A, Vellody R. et al. Image-guided percutaneous core needle biopsy of soft-tissue masses in the pediatric population. Pediatr Radiol 2016; 46 (08) 1173-1178
• 16 Blondiaux E, Laurent M, Audureau E. et al. Factors influencing the diagnostic yield and accuracy of image-guided percutaneous needle biopsy of pediatric tumors: single-center audit of a 26-year experience. Pediatr Radiol 2016; 46 (03) 372-382
• 17 Frush DP, Donnelly LF, Rosen NS. Computed tomography and radiation risks: what pediatric health care providers should know. Pediatrics 2003; 112 (04) 951-957
• 18 Ehrlich PF, Ritchey ML, Hamilton TE. et al. Quality assessment for Wilms' tumor: a report from the National Wilms' Tumor Study-5. J Pediatr Surg 2005; 40 (01) 208-212 , discussion 212–213
• 19 Shamberger RC, Guthrie KA, Ritchey ML. et al. Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4. Ann Surg 1999; 229 (02) 292-297
• 20 Hamilton TE, Green DM, Perlman EJ. et al. Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study. J Pediatr Surg 2006; 41 (10) 1641-1644
• 21 Roth L, Moerdler S, Weiser D, Douglas L, Gill J, Roth M. Otolaryngologist and pediatric oncologist perspectives on the role of fine needle aspiration in diagnosing pediatric head and neck masses. Int J Pediatr Otorhinolaryngol 2019; 121: 34-40
• 22 Francis GL, Waguespack SG, Bauer AJ. et al; American Thyroid Association Guidelines Task Force. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 2015; 25 (07) 716-759
• 23 Nelson O, Bailey Jr PD. Pediatric anesthesia considerations for interventional radiology. Anesthesiol Clin 2017; 35 (04) 701-714
• 24 Aguado A. Role of interventional radiology in pediatric cancer patients. Curr Oncol Rep 2022; 24 (12) 1731-1740
• 25 Harned II RK, Heran MKS, Patel M. et al; 2018 Society of Pediatric Interventional Radiology Board of Directors. Challenges and opportunities for continued success and growth of pediatric interventional radiology: a communiqué from the Society for Pediatric Interventional Radiology. AJR Am J Roentgenol 2018; 211 (04) 740-743
• 26 Zambaiti E, Siles Hinojosa A, Montano V. et al. Interventional radiology-guided procedures in the treatment of pediatric solid tumors: a systematic review and meta-analysis. Eur J Pediatr Surg 2020; 30 (04) 317-325
• 27 Alonso Sánchez J, Parra DA, Parra-Fariñas C. Paediatric interventional radiology: it's not child's play. Radiologia (Engl Ed) 2024; 66 (02) 181-185